Skip to content
hema.to

hema.to

MedTech·Germany·Active
Entry
–
Hold
–
Status
Active

Who owns hema.to?

hema.to is a German MedTech company, currently owned by Heal Capital since 2023 and 4 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Lazard Elaia Capital
Most recent investor
Lazard Elaia Capital
Lazard Elaia Capital Fund I · 2025 · Growth
5 ownership periods · full history below

Key facts

HQGermany
SectorMedTech
Key takeaways
  • ·Co-held by Bayern Kapital, Heal Capital, High-Tech Gruenderfonds (HTGF), Elaia Partners and Lazard Elaia Capital since 2022.
  • ·5 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Co-invest · 4 holders · 2022 · present
Bayern Kapital
2022 · present(4yr) · Seedfonds Bayern · 1996 · VC
Elaia Partners
2023 · present(3yr) · DTS3 · 2024 · VC
High-Tech Gruenderfonds (HTGF)
2023 · present(3yr) · HTGF IV · 2022 · VC
Heal Capital
2023 · present(3yr) · Heal Capital Fund I · 2020 · VC
Lazard Elaia Capital
present · Lazard Elaia Capital Fund I · 2025 · Growth

Questions

Who owns hema.to?

hema.to is currently owned by Heal Capital, High-Tech Gruenderfonds (HTGF) and 3 others, through Lazard Elaia Capital Fund I, since 2023.

When did Heal Capital and 4 others acquire hema.to?

Heal Capital and 4 others acquired hema.to in 2023.

Who has owned hema.to over time?

hema.to has been through 5 private-equity ownership periods: Bayern Kapital · via Seedfonds Bayern · since 2022; Heal Capital · via Heal Capital Fund I · since 2023; High-Tech Gruenderfonds (HTGF) · via HTGF IV · since 2023; Elaia Partners · via DTS3 · since 2023; Lazard Elaia Capital · via Lazard Elaia Capital Fund I.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue